1. Home
  2. CHRO vs UPXI Comparison

CHRO vs UPXI Comparison

Compare CHRO & UPXI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CHRO
  • UPXI
  • Stock Information
  • Founded
  • CHRO 2002
  • UPXI 2018
  • Country
  • CHRO United States
  • UPXI United States
  • Employees
  • CHRO N/A
  • UPXI N/A
  • Industry
  • CHRO
  • UPXI Medicinal Chemicals and Botanical Products
  • Sector
  • CHRO
  • UPXI Health Care
  • Exchange
  • CHRO Nasdaq
  • UPXI Nasdaq
  • Market Cap
  • CHRO 3.8M
  • UPXI 3.9M
  • IPO Year
  • CHRO 2024
  • UPXI 2021
  • Fundamental
  • Price
  • CHRO $1.90
  • UPXI $3.46
  • Analyst Decision
  • CHRO Strong Buy
  • UPXI Hold
  • Analyst Count
  • CHRO 1
  • UPXI 1
  • Target Price
  • CHRO N/A
  • UPXI $25.00
  • AVG Volume (30 Days)
  • CHRO 855.2K
  • UPXI 50.7K
  • Earning Date
  • CHRO 02-20-2025
  • UPXI 02-12-2025
  • Dividend Yield
  • CHRO N/A
  • UPXI N/A
  • EPS Growth
  • CHRO N/A
  • UPXI N/A
  • EPS
  • CHRO N/A
  • UPXI N/A
  • Revenue
  • CHRO N/A
  • UPXI $22,082,477.00
  • Revenue This Year
  • CHRO N/A
  • UPXI $299.03
  • Revenue Next Year
  • CHRO N/A
  • UPXI N/A
  • P/E Ratio
  • CHRO N/A
  • UPXI N/A
  • Revenue Growth
  • CHRO N/A
  • UPXI N/A
  • 52 Week Low
  • CHRO $0.45
  • UPXI $2.17
  • 52 Week High
  • CHRO $6.00
  • UPXI $33.00
  • Technical
  • Relative Strength Index (RSI)
  • CHRO 86.63
  • UPXI 39.66
  • Support Level
  • CHRO $0.81
  • UPXI $3.31
  • Resistance Level
  • CHRO $1.10
  • UPXI $4.10
  • Average True Range (ATR)
  • CHRO 0.26
  • UPXI 0.41
  • MACD
  • CHRO 0.08
  • UPXI -0.04
  • Stochastic Oscillator
  • CHRO 70.64
  • UPXI 9.38

About CHRO Chromocell Therapeutics Corporation

Channel Therapeutics Corp is a clinical-stage biotechnology company developing and commercializing novel, non-opioid, non-addictive therapeutics to alleviate pain. The initial clinical focus is to selectively target the sodium ion channel known as NaV1.7 for the treatment of various types of chronic pain, acute and chronic eye pain, and post-surgical nerve blocks. Its pipeline includes CC8464 for ISFN and EM and CT2000 for Acute and CHronic Eye Pain-Dry Eye Disease.

About UPXI Upexi Inc.

Upexi Inc specializes in the development, manufacturing, and distribution of consumer products. It reaches consumers through its direct-to-consumer network, wholesale partnerships, and prominent third-party platforms like Amazon.

Share on Social Networks: